Delivery Order SPE2DB24D1034-SPE2DB24FWAL1
Award Date
6/10/24
Potential Completion Date
6/11/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,064.14 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military healthcare programs. The $3,065.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,611.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to support Defense Logistics Agency (DLA) Troop Support Medical operations. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The award, valued at $6,320.92, is a firm-fixed price delivery order contract with a completion date of January 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cyclosporine 0.05% eye emulsion to the government. The $7,560.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 3, 2025, with a completion date of January 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,082.76 and a performance period through March 19, 2024. The contract does not have a set-aside designation....
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, which is a prominent pharmaceutical distributor and supplier to the U.S. federal government. The contract has a ceiling value of $14,367.91 and is a delivery order with a firm fixed price. It is not designated as a set-aside contract. The period of performance for this...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,031.36 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of...